Patents by Inventor Suzanne Bruhn

Suzanne Bruhn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SHP1 AND SHP2 INHIBITORS AND THEIR METHODS OF USE
    Publication number: 20220296616
    Abstract: Described herein, in one embodiment, are methods of treating neuroinflammation and other disorders in a subject in need thereof, comprising administering to the subject an effective amount of a compound described herein, e.g., a SHP1 inhibitor or SHP2 inhibitor, or pharmaceutical composition thereof.
    Type: Application
    Filed: June 10, 2022
    Publication date: September 22, 2022
    Applicant: Tiaki Therapeutics Inc.
    Inventors: Thomas Allen Miller, Jonathan Max Levenson, Lauren Martens, Kelley Cronin Larson, Suzanne Bruhn
  • METHODS FOR TREATING FIBROTIC CANCERS
    Publication number: 20210322515
    Abstract: In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
    Type: Application
    Filed: April 27, 2021
    Publication date: October 21, 2021
    Inventors: Suzanne Bruhn, Elizabeth Trehu, Mark Lupher, Jr.
  • Methods for treating fibrotic cancers
    Patent number: 11020451
    Abstract: In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
    Type: Grant
    Filed: October 8, 2014
    Date of Patent: June 1, 2021
    Assignee: PROMEDIOR, INC.
    Inventors: Suzanne Bruhn, Elizabeth Trehu, Mark Lupher, Jr.
  • METHODS FOR TREATING FIBROTIC CANCERS
    Publication number: 20160235812
    Abstract: In part, the disclosure relates to methods of treating fibrotic cancers by administering one or more Serum Amyloid Protein (SAP) agonists. In certain aspects, the method further comprises the conjoint administration of an anti-cancer therapeutic, e.g., a chemotherapeutic agent. In certain aspects, the disclosure relates to methods of treating myelofibrosis by administering an SAP agonist and optionally one or more anti-cancer therapeutic agents.
    Type: Application
    Filed: October 8, 2014
    Publication date: August 18, 2016
    Inventors: Suzanne Bruhn, Elizabeth Trehu, Mark Lupher